|
US2685553A
(en)
|
1951-03-30 |
1954-08-03 |
Winthrop Stearns Inc |
Cement coated tablets
|
|
DE2010416B2
(de)
|
1970-03-05 |
1979-03-29 |
Hoechst Ag, 6000 Frankfurt |
Oral anwendbare Arzneiform mit Retardwirkung
|
|
DE2815926A1
(de)
|
1978-04-13 |
1979-10-18 |
Boehringer Mannheim Gmbh |
Neue carbazolyl-(4)-oxy-propanolamin-derivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
|
|
CA1018456A
(en)
|
1972-06-26 |
1977-10-04 |
Hans Lowey |
Prolonged release lozenges
|
|
JPS5518694B2
(enExample)
|
1973-04-02 |
1980-05-21 |
|
|
|
US4034758A
(en)
|
1975-09-08 |
1977-07-12 |
Alza Corporation |
Osmotic therapeutic system for administering medicament
|
|
US4330338A
(en)
|
1978-10-02 |
1982-05-18 |
Purdue Research Foundation |
Pharmaceutical coating composition, and preparation and dosages so coated
|
|
US4449983A
(en)
|
1982-03-22 |
1984-05-22 |
Alza Corporation |
Simultaneous delivery of two drugs from unit delivery device
|
|
US4389393A
(en)
|
1982-03-26 |
1983-06-21 |
Forest Laboratories, Inc. |
Sustained release therapeutic compositions based on high molecular weight hydroxypropylmethylcellulose
|
|
DE3320583A1
(de)
|
1983-06-08 |
1984-12-13 |
Dr. Karl Thomae Gmbh, 7950 Biberach |
Neue galenische zubereitungsformen von oralen antidiabetika und verfahren zu ihrer herstellung
|
|
AU591171B2
(en)
|
1983-11-02 |
1989-11-30 |
Alza Corporation |
Dispenser for delivering thermo-responsive composition
|
|
US4844984A
(en)
|
1984-03-19 |
1989-07-04 |
Alza Corporation |
Dispensing system with means for increasing delivery of beneficial agent from the system
|
|
JPH0246008B2
(ja)
|
1984-06-01 |
1990-10-12 |
Takada Seiyaku Kk |
Nifuejipinjizokuseiseizainoseizohoho
|
|
GB2170104A
(en)
|
1985-01-30 |
1986-07-30 |
Warner Lambert Co |
Coated pharmaceutical dosage forms
|
|
IE59066B1
(en)
|
1985-02-19 |
1993-12-15 |
Key Pharma |
Controlled release potassium chloride
|
|
US4898733A
(en)
|
1985-11-04 |
1990-02-06 |
International Minerals & Chemical Corp. |
Layered, compression molded device for the sustained release of a beneficial agent
|
|
US4892742A
(en)
|
1985-11-18 |
1990-01-09 |
Hoffmann-La Roche Inc. |
Controlled release compositions with zero order release
|
|
US4824675A
(en)
|
1987-07-13 |
1989-04-25 |
Alza Corporation |
Dispenser with movable matrix comprising a plurality of tiny pills
|
|
EP0406315B1
(en)
|
1988-03-24 |
1992-11-11 |
Bukh Meditec A/S |
Controlled release composition
|
|
FI101344B
(fi)
|
1988-03-31 |
1998-06-15 |
Tanabe Seiyaku Co |
Menetelmä valmistaa valmiste, josta kontrolloidusti vapautuu farmaseut tisesti aktiivista ainetta
|
|
JPH07100191B2
(ja)
|
1989-01-04 |
1995-11-01 |
古河電気工業株式会社 |
ブランキング方法
|
|
AU621182B2
(en)
|
1989-01-30 |
1992-03-05 |
Alza Corporation |
Dosage form for administering calcium antagonist
|
|
US5019396A
(en)
|
1989-05-12 |
1991-05-28 |
Alza Corporation |
Delivery dispenser for treating cardiac arrhythmias
|
|
DK469989D0
(da)
|
1989-09-22 |
1989-09-22 |
Bukh Meditec |
Farmaceutisk praeparat
|
|
IT1237904B
(it)
|
1989-12-14 |
1993-06-18 |
Ubaldo Conte |
Compresse a rilascio a velocita' controllata delle sostanze attive
|
|
EP0435726B1
(en)
|
1989-12-29 |
1994-11-09 |
Bristol-Myers Squibb Company |
Capsule and caplet combination
|
|
US5102668A
(en)
|
1990-10-05 |
1992-04-07 |
Kingaform Technology, Inc. |
Sustained release pharmaceutical preparation using diffusion barriers whose permeabilities change in response to changing pH
|
|
GB9025372D0
(en)
|
1990-11-22 |
1991-01-09 |
Nat Res Dev |
Pharmaceutical dosage forms
|
|
GB9101502D0
(en)
|
1991-01-23 |
1991-03-06 |
Controlled Therapeutics Sct |
Controlled release compositions
|
|
US5266331A
(en)
|
1991-11-27 |
1993-11-30 |
Euroceltique, S.A. |
Controlled release oxycodone compositions
|
|
US5656295A
(en)
|
1991-11-27 |
1997-08-12 |
Euro-Celtique, S.A. |
Controlled release oxycodone compositions
|
|
US5478577A
(en)
|
1993-11-23 |
1995-12-26 |
Euroceltique, S.A. |
Method of treating pain by administering 24 hour oral opioid formulations exhibiting rapid rate of initial rise of plasma drug level
|
|
US5968551A
(en)
|
1991-12-24 |
1999-10-19 |
Purdue Pharma L.P. |
Orally administrable opioid formulations having extended duration of effect
|
|
SE9202250D0
(sv)
|
1992-07-29 |
1992-07-29 |
Gacell Lab Ab |
Controlled release morphine preparation
|
|
US5609885A
(en)
|
1992-09-15 |
1997-03-11 |
Alza Corporation |
Osmotic membrane and delivery device
|
|
US5869097A
(en)
|
1992-11-02 |
1999-02-09 |
Alza Corporation |
Method of therapy comprising an osmotic caplet
|
|
US5881926A
(en)
|
1993-03-11 |
1999-03-16 |
Taro Pharmaceutical Industries, Ltd. |
Pharmaceutical compositions in semisolid form and a device for administration thereof
|
|
SE9301057L
(sv)
|
1993-03-30 |
1994-10-01 |
Pharmacia Ab |
Beredning med kontrollerad frisättning
|
|
US5656291A
(en)
|
1994-03-16 |
1997-08-12 |
Pharmacia & Upjohn Aktiebolag |
Controlled release preparation
|
|
IL110014A
(en)
|
1993-07-01 |
1999-11-30 |
Euro Celtique Sa |
Solid controlled-release oral dosage forms of opioid analgesics
|
|
US5879705A
(en)
|
1993-07-27 |
1999-03-09 |
Euro-Celtique S.A. |
Sustained release compositions of morphine and a method of preparing pharmaceutical compositions
|
|
US6183778B1
(en)
|
1993-09-21 |
2001-02-06 |
Jagotec Ag |
Pharmaceutical tablet capable of liberating one or more drugs at different release rates
|
|
US5419917A
(en)
|
1994-02-14 |
1995-05-30 |
Andrx Pharmaceuticals, Inc. |
Controlled release hydrogel formulation
|
|
AU1806895A
(en)
|
1994-02-23 |
1995-09-11 |
Bm Research A/S |
Controlled release composition
|
|
US6077533A
(en)
|
1994-05-25 |
2000-06-20 |
Purdue Pharma L.P. |
Powder-layered oral dosage forms
|
|
US7060293B1
(en)
|
1994-05-25 |
2006-06-13 |
Purdue Pharma |
Powder-layered oral dosage forms
|
|
US5411745A
(en)
|
1994-05-25 |
1995-05-02 |
Euro-Celtique, S.A. |
Powder-layered morphine sulfate formulations
|
|
US5460826A
(en)
|
1994-06-27 |
1995-10-24 |
Alza Corporation |
Morphine therapy
|
|
US6491945B1
(en)
|
1994-09-16 |
2002-12-10 |
Alza Corporation |
Hydrocodone therapy
|
|
US5965161A
(en)
|
1994-11-04 |
1999-10-12 |
Euro-Celtique, S.A. |
Extruded multi-particulates
|
|
IL116674A
(en)
|
1995-01-09 |
2003-05-29 |
Mendell Co Inc Edward |
Microcrystalline cellulose-based excipient having improved compressibility, pharmaceutical compositions containing the same and methods for the preparation of said excipient and of solid dosage form thereof
|
|
DE69632684T2
(de)
|
1995-06-27 |
2005-06-09 |
Takeda Pharmaceutical Co. Ltd. |
Verfahren zur herstellung von zubereitungen mit verzögerter freisetzung
|
|
GB9519363D0
(en)
|
1995-09-22 |
1995-11-22 |
Euro Celtique Sa |
Pharmaceutical formulation
|
|
US6245351B1
(en)
|
1996-03-07 |
2001-06-12 |
Takeda Chemical Industries, Ltd. |
Controlled-release composition
|
|
PT914097E
(pt)
|
1996-03-12 |
2002-06-28 |
Alza Corp |
Composicao e forma de dosagem compreendendo antagonista de opioide
|
|
DE69739215D1
(de)
|
1996-05-20 |
2009-03-05 |
Otsuka Pharma Co Ltd |
Heilmittel fuer rosazla
|
|
US6348216B1
(en)
|
1996-06-10 |
2002-02-19 |
Knoll Pharmaceutical Company |
Ibuprofen and narcotic analgesic compositions
|
|
US6361794B1
(en)
|
1996-06-12 |
2002-03-26 |
Basf Corporation |
Method of making ibuprofen and narcotic analgesic composition
|
|
JP2000516222A
(ja)
|
1996-08-15 |
2000-12-05 |
ロザン ファルマ ゲゼルシャフトミットベシュレンクテル ハフツング |
嚥下が容易な経口医薬組成物
|
|
US5948787A
(en)
|
1997-02-28 |
1999-09-07 |
Alza Corporation |
Compositions containing opiate analgesics
|
|
US6046177A
(en)
|
1997-05-05 |
2000-04-04 |
Cydex, Inc. |
Sulfoalkyl ether cyclodextrin based controlled release solid pharmaceutical formulations
|
|
IL133080A0
(en)
|
1997-07-01 |
2001-03-19 |
Pfizer |
Sertraline salts and sustained-release dosage forms of sertraline
|
|
US6730326B2
(en)
|
1997-07-22 |
2004-05-04 |
Roche Diagnostics Gmbh |
Thermodynamically stable modification of 1-(4-carbazolyl-oxy-3[2-(2-methoxyphenoxy)-ethylamino]-2-propanol process for its preparation and pharmaceutical compositions containing it
|
|
US6607751B1
(en)
|
1997-10-10 |
2003-08-19 |
Intellipharamaceutics Corp. |
Controlled release delivery device for pharmaceutical agents incorporating microbial polysaccharide gum
|
|
US6066339A
(en)
|
1997-10-17 |
2000-05-23 |
Elan Corporation, Plc |
Oral morphine multiparticulate formulation
|
|
US20020054911A1
(en)
|
2000-05-11 |
2002-05-09 |
Boehringer Mannheim Pharmaceutical Corporation-Sm Ithkline Beckman Corporation, Limited Partnershi |
Novel oral dosage form for carvedilol
|
|
US6375957B1
(en)
|
1997-12-22 |
2002-04-23 |
Euro-Celtique, S.A. |
Opioid agonist/opioid antagonist/acetaminophen combinations
|
|
TR200001942T2
(tr)
|
1997-12-22 |
2000-11-21 |
Euro-Celtique, S.A. |
Opioid agonist/antagonist kombinasyonlar
|
|
FR2774910B1
(fr)
|
1998-02-16 |
2001-09-07 |
Ethypharm Lab Prod Ethiques |
Microgranules de sulfate de morphine, procede de fabrication et preparations pharmaceutiques
|
|
US8524277B2
(en)
|
1998-03-06 |
2013-09-03 |
Alza Corporation |
Extended release dosage form
|
|
US6245357B1
(en)
|
1998-03-06 |
2001-06-12 |
Alza Corporation |
Extended release dosage form
|
|
US6350470B1
(en)
|
1998-04-29 |
2002-02-26 |
Cima Labs Inc. |
Effervescent drug delivery system for oral administration
|
|
DK1067910T3
(da)
|
1998-04-03 |
2004-10-04 |
Egalet As |
Komposition med styret afgivelse
|
|
US7906143B1
(en)
|
1998-10-05 |
2011-03-15 |
Intellipharmaceutics Corp |
Controlled release pharmaceutical delivery device and process for preparation thereof
|
|
US20080113025A1
(en)
|
1998-11-02 |
2008-05-15 |
Elan Pharma International Limited |
Compositions comprising nanoparticulate naproxen and controlled release hydrocodone
|
|
US20080102121A1
(en)
|
1998-11-02 |
2008-05-01 |
Elan Pharma International Limited |
Compositions comprising nanoparticulate meloxicam and controlled release hydrocodone
|
|
ATE433318T1
(de)
|
1999-02-10 |
2009-06-15 |
Pfizer Prod Inc |
Osmotisches system zur verabreichung von wirkstoffen, die feste amorphe dispersionen enthalten
|
|
CA2328614C
(en)
|
1999-02-12 |
2012-06-26 |
Biostream, Inc. |
Matrices for drug delivery and methods for making and using the same
|
|
US6267985B1
(en)
|
1999-06-30 |
2001-07-31 |
Lipocine Inc. |
Clear oil-containing pharmaceutical compositions
|
|
US6383471B1
(en)
|
1999-04-06 |
2002-05-07 |
Lipocine, Inc. |
Compositions and methods for improved delivery of ionizable hydrophobic therapeutic agents
|
|
FR2794646B1
(fr)
|
1999-06-09 |
2001-09-21 |
Ethypharm Lab Prod Ethiques |
Microgranules de sulfate de morphine, procede de preparation et composition les contenant
|
|
US6225343B1
(en)
|
1999-06-16 |
2001-05-01 |
Nastech Pharmaceutical Company, Inc. |
Compositions and methods comprising morphine gluconate
|
|
US20030118641A1
(en)
|
2000-07-27 |
2003-06-26 |
Roxane Laboratories, Inc. |
Abuse-resistant sustained-release opioid formulation
|
|
US6562375B1
(en)
|
1999-08-04 |
2003-05-13 |
Yamanouchi Pharmaceuticals, Co., Ltd. |
Stable pharmaceutical composition for oral use
|
|
US6534085B1
(en)
|
1999-09-23 |
2003-03-18 |
Bioresponse L.L.C. |
Phytochemicals for promoting weight loss
|
|
EP2295043A1
(en)
|
1999-10-29 |
2011-03-16 |
Euro-Celtique S.A. |
Controlled release hydrocodone formulations
|
|
US6515010B1
(en)
|
1999-11-15 |
2003-02-04 |
Smithkline Beecham Corporation |
Carvedilol methanesulfonate
|
|
US6458824B1
(en)
|
1999-11-30 |
2002-10-01 |
Dainippon Pharmaceutical Co., Ltd. |
Solid preparation
|
|
US6352721B1
(en)
|
2000-01-14 |
2002-03-05 |
Osmotica Corp. |
Combined diffusion/osmotic pumping drug delivery system
|
|
US6491949B2
(en)
|
2000-01-14 |
2002-12-10 |
Osmotica Corp. |
Osmotic device within an osmotic device
|
|
AR028253A1
(es)
|
2000-03-16 |
2003-04-30 |
Pfizer Prod Inc |
Inhibidores de la glucogeno fosforilasa
|
|
US20010036959A1
(en)
|
2000-04-03 |
2001-11-01 |
Gabel Rolf Dieter |
Carvedilol-hydrophilic solutions
|
|
WO2001074356A1
(en)
|
2000-04-03 |
2001-10-11 |
F. Hoffmann-La Roche Ag |
Concentrated solutions of carvedilol
|
|
US6488962B1
(en)
|
2000-06-20 |
2002-12-03 |
Depomed, Inc. |
Tablet shapes to enhance gastric retention of swellable controlled-release oral dosage forms
|
|
EP1335707A4
(en)
|
2000-10-24 |
2005-07-06 |
Smithkline Beecham Corp |
NEW CARVEDILOL FORMULATIONS
|
|
AU2002227383B2
(en)
|
2000-10-30 |
2004-07-08 |
Euro-Celtique S.A. |
Controlled release hydrocodone formulations
|
|
ATE293439T1
(de)
|
2000-12-07 |
2005-05-15 |
Warner Lambert Co |
Verfahren und system zur gleichmä igen arzneistoffabgabe
|
|
US6800668B1
(en)
|
2001-01-19 |
2004-10-05 |
Intellipharmaceutics Corp. |
Syntactic deformable foam compositions and methods for making
|
|
US20110104214A1
(en)
|
2004-04-15 |
2011-05-05 |
Purdue Pharma L.P. |
Once-a-day oxycodone formulations
|
|
UA81224C2
(uk)
|
2001-05-02 |
2007-12-25 |
Euro Celtic S A |
Дозована форма оксикодону та її застосування
|
|
IN191028B
(enExample)
|
2001-05-17 |
2003-09-13 |
Sun Pharmaceutical Ind Ltd |
|
|
US7332182B2
(en)
|
2001-08-06 |
2008-02-19 |
Purdue Pharma L.P. |
Pharmaceutical formulation containing opioid agonist, opioid antagonist and irritant
|
|
IL160217A0
(en)
*
|
2001-08-06 |
2004-07-25 |
Euro Celtique Sa |
Compositions and methods to prevent abuse of opioids
|
|
US7842307B2
(en)
|
2001-08-06 |
2010-11-30 |
Purdue Pharma L.P. |
Pharmaceutical formulation containing opioid agonist, opioid antagonist and gelling agent
|
|
US7144587B2
(en)
|
2001-08-06 |
2006-12-05 |
Euro-Celtique S.A. |
Pharmaceutical formulation containing opioid agonist, opioid antagonist and bittering agent
|
|
US20030068375A1
(en)
|
2001-08-06 |
2003-04-10 |
Curtis Wright |
Pharmaceutical formulation containing gelling agent
|
|
US20040253310A1
(en)
|
2001-09-21 |
2004-12-16 |
Gina Fischer |
Morphine polymer release system
|
|
US20050019399A1
(en)
|
2001-09-21 |
2005-01-27 |
Gina Fischer |
Controlled release solid dispersions
|
|
WO2003024429A1
(en)
|
2001-09-21 |
2003-03-27 |
Egalet A/S |
Polymer release system
|
|
MXPA04002973A
(es)
|
2001-09-28 |
2005-06-20 |
Johnson & Johnson |
Formas de dosis de liberacion modificada.
|
|
US8765167B2
(en)
|
2001-10-12 |
2014-07-01 |
Monosol Rx, Llc |
Uniform films for rapid-dissolve dosage form incorporating anti-tacking compositions
|
|
US20060039958A1
(en)
|
2003-05-28 |
2006-02-23 |
Monosolrx, Llc. |
Multi-layer films having uniform content
|
|
US7666337B2
(en)
|
2002-04-11 |
2010-02-23 |
Monosol Rx, Llc |
Polyethylene oxide-based films and drug delivery systems made therefrom
|
|
US8603514B2
(en)
|
2002-04-11 |
2013-12-10 |
Monosol Rx, Llc |
Uniform films for rapid dissolve dosage form incorporating taste-masking compositions
|
|
US20070281003A1
(en)
|
2001-10-12 |
2007-12-06 |
Fuisz Richard C |
Polymer-Based Films and Drug Delivery Systems Made Therefrom
|
|
ITMI20012366A1
(it)
|
2001-11-09 |
2003-05-09 |
Farmatron Ltd |
Sistemi terapeutici stabilizzati a rilascio immediato e/o modificato per la somministrazione orale di principi attivi e/o eccipienti e/o ali
|
|
NZ535008A
(en)
|
2002-02-08 |
2005-09-30 |
Alkermes Inc |
Polymer-based compositions for sustained release
|
|
ITMI20020514A1
(it)
|
2002-03-12 |
2003-09-12 |
Jagotec Ag |
Sistema terapeutico per il rilascio controllato di uno o piu' principi attivi
|
|
PT1485078E
(pt)
|
2002-03-15 |
2013-01-14 |
Cypress Bioscience Inc |
Milnacipran para o tratamento do síndrome do intestino irritável
|
|
PT1578350E
(pt)
|
2002-03-26 |
2009-08-27 |
Euro Celtique Sa |
Composições revestidas com geles de libertação constante
|
|
US8017150B2
(en)
|
2002-04-11 |
2011-09-13 |
Monosol Rx, Llc |
Polyethylene oxide-based films and drug delivery systems made therefrom
|
|
US20050106249A1
(en)
|
2002-04-29 |
2005-05-19 |
Stephen Hwang |
Once-a-day, oral, controlled-release, oxycodone dosage forms
|
|
MXPA04010769A
(es)
|
2002-04-29 |
2005-07-05 |
Alza Corp |
Metodos y formas de dosificacion para suministro controlado de oxicodona.
|
|
DE10223844B4
(de)
|
2002-05-28 |
2013-04-04 |
Danfoss A/S |
Wasserhydraulische Maschine
|
|
CA2487786A1
(en)
|
2002-05-31 |
2003-12-11 |
Alza Corporation |
Dosage forms and compositions for osmotic delivery of variable dosages of oxycodone
|
|
AR039744A1
(es)
|
2002-06-26 |
2005-03-09 |
Alza Corp |
Metodos y formas de dosificacion para aumentar la solubilidad de las composiciones de farmacos para la administracion controlada
|
|
US6632832B1
(en)
|
2002-09-10 |
2003-10-14 |
Dabur Research Foundation |
Anti-cancer activity of carvedilol and its isomers
|
|
WO2004041252A1
(en)
|
2002-11-08 |
2004-05-21 |
Egalet A/S |
Controlled release carvedilol compositions
|
|
US20040089605A1
(en)
|
2002-11-08 |
2004-05-13 |
Harry Brandt |
Reverse osmosis liquid purification system and method
|
|
US20040102476A1
(en)
|
2002-11-25 |
2004-05-27 |
Chan Tai Wah |
High concentration formulations of opioids and opioid derivatives
|
|
EP2218448B1
(en)
|
2002-12-13 |
2015-09-23 |
Durect Corporation |
Oral drug delivery system comprising high viscosity liquid carrier materials
|
|
US20040224020A1
(en)
|
2002-12-18 |
2004-11-11 |
Schoenhard Grant L. |
Oral dosage forms with therapeutically active agents in controlled release cores and immediate release gelatin capsule coats
|
|
US8877241B2
(en)
|
2003-03-26 |
2014-11-04 |
Egalet Ltd. |
Morphine controlled release system
|
|
DE602004014747D1
(de)
|
2003-03-26 |
2008-08-14 |
Egalet As |
Matrixzubereitungen für die kontrollierte darreichung von arzneistoffen
|
|
US20040202717A1
(en)
|
2003-04-08 |
2004-10-14 |
Mehta Atul M. |
Abuse-resistant oral dosage forms and method of use thereof
|
|
JP5501553B2
(ja)
|
2003-04-21 |
2014-05-21 |
ユーロ−セルティーク エス．エイ． |
同時押出逆作用剤粒子を含有する改変防止剤形およびその製造工程
|
|
SI1631251T1
(sl)
|
2003-04-24 |
2011-10-28 |
Jagotec Ag |
Tableta z zakasnjenim sproščanjem in definirano geometrijo jedra
|
|
US20060177507A1
(en)
|
2003-05-22 |
2006-08-10 |
Joaquina Faour |
Controlled release device containing lercanidipine
|
|
US8029822B2
(en)
|
2003-05-22 |
2011-10-04 |
Osmotica Kereskedelmi és Seolgáltató KFT |
Rupturing controlled release device having a preformed passageway
|
|
BRPI0410956A
(pt)
|
2003-05-28 |
2006-07-04 |
Monosolrx Llc |
pelìculas com base em óxido de polietileno e sistemas de liberação de droga feitos delas
|
|
US20060165790A1
(en)
|
2003-06-27 |
2006-07-27 |
Malcolm Walden |
Multiparticulates
|
|
TWI357815B
(en)
|
2003-06-27 |
2012-02-11 |
Euro Celtique Sa |
Multiparticulates
|
|
EP1646367A4
(en)
|
2003-07-21 |
2011-06-15 |
Nesher Solutions Ltd |
ORAL DOSAGE FORMS WITH CONTROLLED RELEASE ON GELLAN RUBBER BASE A NEW PLATFORM TECHNOLOGY FOR MAGNETIC RETENTION
|
|
US20070048228A1
(en)
|
2003-08-06 |
2007-03-01 |
Elisabeth Arkenau-Maric |
Abuse-proofed dosage form
|
|
US8075872B2
(en)
|
2003-08-06 |
2011-12-13 |
Gruenenthal Gmbh |
Abuse-proofed dosage form
|
|
DE102005005446A1
(de)
|
2005-02-04 |
2006-08-10 |
Grünenthal GmbH |
Bruchfeste Darreichungsformen mit retardierter Freisetzung
|
|
DE102004020220A1
(de)
|
2004-04-22 |
2005-11-10 |
Grünenthal GmbH |
Verfahren zur Herstellung einer gegen Missbrauch gesicherten, festen Darreichungsform
|
|
DE10361596A1
(de)
|
2003-12-24 |
2005-09-29 |
Grünenthal GmbH |
Verfahren zur Herstellung einer gegen Missbrauch gesicherten Darreichungsform
|
|
DE102004032051A1
(de)
|
2004-07-01 |
2006-01-19 |
Grünenthal GmbH |
Verfahren zur Herstellung einer gegen Missbrauch gesicherten, festen Darreichungsform
|
|
PT1842533E
(pt)
|
2003-08-06 |
2013-05-17 |
Gruenenthal Gmbh |
Forma de dosagem protegida contra abuso
|
|
DE10336400A1
(de)
|
2003-08-06 |
2005-03-24 |
Grünenthal GmbH |
Gegen Missbrauch gesicherte Darreichungsform
|
|
US20050053655A1
(en)
|
2003-09-05 |
2005-03-10 |
Pharmaceutical Industry Technology And Development Center |
Rapid disintegrating tablets (RDTs) for pharmaceutical use and method for preparing the same
|
|
EA200600598A1
(ru)
|
2003-09-19 |
2006-08-25 |
Пенвест Фармасьютикалз Ко. |
Лекарственные формы замедленного высвобождения
|
|
NZ546182A
(en)
|
2003-09-26 |
2009-08-28 |
Alza Corp |
Controlled release formulations of opioid and nonopioid analgesics such as hydrocodone and acetaminophen
|
|
WO2005034859A2
(en)
|
2003-10-03 |
2005-04-21 |
Elite Laboratories Inc. |
Extended release formulations of opioids and method of use thereof
|
|
US7201920B2
(en)
|
2003-11-26 |
2007-04-10 |
Acura Pharmaceuticals, Inc. |
Methods and compositions for deterring abuse of opioid containing dosage forms
|
|
US8883204B2
(en)
|
2003-12-09 |
2014-11-11 |
Purdue Pharma L.P. |
Tamper resistant co-extruded dosage form containing an active agent and an adverse agent and process of making same
|
|
ES2293143T3
(es)
|
2003-12-17 |
2008-03-16 |
Ksb Aktiengesellschaft |
Sistema cambiador de presion.
|
|
JP2007516297A
(ja)
|
2003-12-23 |
2007-06-21 |
アルザ・コーポレーシヨン |
制御送達用薬剤組成物の溶解度を高くする方法および投薬形態物
|
|
US20050163837A1
(en)
|
2003-12-31 |
2005-07-28 |
Garth Boehm |
Rosiglitazone formulations
|
|
PL1740156T3
(pl)
|
2004-04-22 |
2011-12-30 |
Gruenenthal Gmbh |
Sposób wytwarzania zabezpieczonej przed nadużyciem, stałej postaci aplikacyjnej
|
|
US8383154B2
(en)
|
2004-05-11 |
2013-02-26 |
Egalet A/S |
Swellable dosage form comprising gellan gum
|
|
ES2653568T3
(es)
|
2004-06-12 |
2018-02-07 |
Collegium Pharmaceutical, Inc. |
Formulaciones de fármacos para la prevención del abuso
|
|
PL1765298T3
(pl)
|
2004-07-01 |
2013-01-31 |
Gruenenthal Gmbh |
Sposób wytwarzania stałej postaci dawkowania, która jest zabezpieczona przez nadużywaniem, wykorzystujący wytłaczarkę z przekładnią planetarną
|
|
DE102004032103A1
(de)
|
2004-07-01 |
2006-01-19 |
Grünenthal GmbH |
Gegen Missbrauch gesicherte, orale Darreichungsform
|
|
CA2572491A1
(en)
|
2004-07-01 |
2006-01-12 |
Gruenenthal Gmbh |
Oral dosage form safeguarded against abuse
|
|
DE102004032049A1
(de)
|
2004-07-01 |
2006-01-19 |
Grünenthal GmbH |
Gegen Missbrauch gesicherte, orale Darreichungsform
|
|
AR053304A1
(es)
|
2004-07-01 |
2007-05-02 |
Gruenenthal Gmbh |
Formas farmaceuticas orales protegidas frente al abuso con liberacion controlada de (1r,2r)-3-(3 dimetilamino-1-etil-2metil-propil)fenol y procedimiento para su produccion.
|
|
DE102004038440A1
(de)
|
2004-08-07 |
2006-03-16 |
Ksb Aktiengesellschaft |
Drehzahlregelbarer Druckaustauscher
|
|
US7214315B2
(en)
|
2004-08-20 |
2007-05-08 |
Scott Shumway |
Pressure exchange apparatus with integral pump
|
|
US20070281007A1
(en)
|
2004-08-27 |
2007-12-06 |
Jacob Jules S |
Mucoadhesive Oral Formulations of High Permeability, High Solubility Drugs
|
|
WO2006030402A2
(en)
|
2004-09-17 |
2006-03-23 |
Ranbaxy Laboratories Limited |
Dual compartment osmotic delivery device
|
|
US20080152595A1
(en)
|
2004-11-24 |
2008-06-26 |
Acura Pharmaceuticals, Inc. |
Methods and compositions for deterring abuse of orally administered pharmaceutical products
|
|
US20070231268A1
(en)
|
2004-11-24 |
2007-10-04 |
Acura Pharmaceuticals, Inc. |
Methods and compositions for deterring abuse of orally administered pharmaceutical products
|
|
US20060110327A1
(en)
|
2004-11-24 |
2006-05-25 |
Acura Pharmaceuticals, Inc. |
Methods and compositions for deterring abuse of orally administered pharmaceutical products
|
|
US20060177380A1
(en)
|
2004-11-24 |
2006-08-10 |
Acura Pharmaceuticals, Inc. |
Methods and compositions for deterring abuse of orally administered pharmaceutical products
|
|
FR2889810A1
(fr)
|
2005-05-24 |
2007-02-23 |
Flamel Technologies Sa |
Forme medicamenteuse orale, microparticulaire, anti-mesurage
|
|
FR2881652B1
(fr)
|
2005-02-08 |
2007-05-25 |
Flamel Technologies Sa |
Forme pharmaceutique orale microparticulaire anti-mesuage
|
|
KR100822519B1
(ko)
|
2005-02-15 |
2008-04-16 |
주식회사종근당 |
위장 내에서 제어방출되는 단일 매트릭스 정제
|
|
US20060193912A1
(en)
|
2005-02-28 |
2006-08-31 |
Penwest Pharmaceuticals Co. |
Controlled release O-desmethylvenlafaxine formulations
|
|
EP1863456A1
(en)
|
2005-03-28 |
2007-12-12 |
Orexo AB |
New pharmaceutical compositions useful in the treatment of pain
|
|
GB0506982D0
(en)
|
2005-04-06 |
2005-05-11 |
Mw Encap Ltd |
Abuse resistant capsules
|
|
NZ563846A
(en)
|
2005-06-03 |
2010-03-26 |
Egalet As |
A drug delivery system for delivering active substances dispersed in a dispersion medium
|
|
PE20070325A1
(es)
|
2005-06-29 |
2007-05-12 |
Alza Corp |
Formas de dosificacion oral que comprenden compuestos derivados de carbamato
|
|
US8858993B2
(en)
|
2005-07-25 |
2014-10-14 |
Metrics, Inc. |
Coated tablet with zero-order or near zero-order release kinetics
|
|
US20080166407A1
(en)
|
2005-07-29 |
2008-07-10 |
Shalaby Shalaby W |
Solid oral formulations for combination therapy
|
|
EP1931305A2
(en)
|
2005-09-09 |
2008-06-18 |
MonoSolRX, LLC |
Uniform films for rapid-dissolve dosage form incorporating anti-tacking compositions
|
|
PL116330U1
(en)
|
2005-10-31 |
2007-04-02 |
Alza Corp |
Method for the reduction of alcohol provoked rapid increase in the released dose of the orally administered opioide with prolonged liberation
|
|
US8652529B2
(en)
|
2005-11-10 |
2014-02-18 |
Flamel Technologies |
Anti-misuse microparticulate oral pharmaceutical form
|
|
US20100172989A1
(en)
|
2006-01-21 |
2010-07-08 |
Abbott Laboratories |
Abuse resistant melt extruded formulation having reduced alcohol interaction
|
|
US20090317355A1
(en)
|
2006-01-21 |
2009-12-24 |
Abbott Gmbh & Co. Kg, |
Abuse resistant melt extruded formulation having reduced alcohol interaction
|
|
RU2433817C2
(ru)
*
|
2006-01-21 |
2011-11-20 |
Эбботт Гмбх Унд Ко.Кг |
Лекарственная форма и способ для доставки вызывающих зависимость лекарственных веществ
|
|
US20090022798A1
(en)
|
2007-07-20 |
2009-01-22 |
Abbott Gmbh & Co. Kg |
Formulations of nonopioid and confined opioid analgesics
|
|
US20070264346A1
(en)
|
2006-02-16 |
2007-11-15 |
Flamel Technologies |
Multimicroparticulate pharmaceutical forms for oral administration
|
|
ZA200807571B
(en)
|
2006-03-01 |
2009-08-26 |
Ethypharm Sa |
Crush-resistant tablets intended to prevent accidental misuse and unlawful diversion
|
|
EP1993519A4
(en)
|
2006-03-15 |
2011-12-21 |
Acura Pharmaceuticals Inc |
METHOD AND COMPOSITIONS FOR PREVENTING THE ABUSE OF ORGANIC PRODUCTS MANIPULATED ORAL
|
|
ATE536867T1
(de)
|
2006-03-16 |
2011-12-15 |
Tris Pharma Inc |
Modifizierte freisetzungsformulierungen mit arznei-ion-austausch-harzkomplexen
|
|
CN101489756B
(zh)
|
2006-03-24 |
2013-08-07 |
奥克思利尤姆国际控股公司 |
热熔挤出层压材料的制备方法
|
|
CN101484142B
(zh)
|
2006-03-24 |
2013-06-05 |
奥克思利尤姆国际控股公司 |
包含对碱性不稳定的药物的稳定组合物
|
|
PL2457563T3
(pl)
|
2006-05-09 |
2017-09-29 |
Mallinckrodt Llc |
Stałe postacie dawkowania o zmodyfikowanym uwalnianiu rzędu zerowego
|
|
US10960077B2
(en)
|
2006-05-12 |
2021-03-30 |
Intellipharmaceutics Corp. |
Abuse and alcohol resistant drug composition
|
|
FR2901478B1
(fr)
|
2006-05-24 |
2015-06-05 |
Flamel Tech Sa |
Forme pharmaceutique orale multimicroparticulaire a liberation prolongee
|
|
US9023400B2
(en)
|
2006-05-24 |
2015-05-05 |
Flamel Technologies |
Prolonged-release multimicroparticulate oral pharmaceutical form
|
|
US20080069891A1
(en)
|
2006-09-15 |
2008-03-20 |
Cima Labs, Inc. |
Abuse resistant drug formulation
|
|
JP2009541359A
(ja)
|
2006-06-23 |
2009-11-26 |
エラン・ファルマ・インターナショナル・リミテッド |
ナノ粒子状ナプロキセンおよび制御放出ヒドロコドンを含む組成物
|
|
JP2009541360A
(ja)
|
2006-06-23 |
2009-11-26 |
エラン・ファルマ・インターナショナル・リミテッド |
ナノ粒子状メロキシカムおよび制御放出ヒドロコドンを含む組成物
|
|
MX2009001294A
(es)
|
2006-08-04 |
2009-05-21 |
Ethypharm Sa |
Granulo y tableta que se desintegra por vía oral que comprende oxicodona.
|
|
SA07280459B1
(ar)
|
2006-08-25 |
2011-07-20 |
بيورديو فارما إل. بي. |
أشكال جرعة صيدلانية للتناول عن طريق الفم مقاومة للعبث تشتمل على مسكن شبه أفيوني
|
|
WO2008027442A2
(en)
|
2006-08-30 |
2008-03-06 |
Theraquest Biosciences, Llc |
Abuse deterrent oral pharmaceutical formulations of opioid agonists and method of use
|
|
WO2008028047A2
(en)
|
2006-08-30 |
2008-03-06 |
Lab International Srl |
Bioadhesive film drug delivery system
|
|
US8445018B2
(en)
|
2006-09-15 |
2013-05-21 |
Cima Labs Inc. |
Abuse resistant drug formulation
|
|
US8211905B1
(en)
|
2007-05-22 |
2012-07-03 |
Pisgah Laboratories, Inc. |
Opioid salts and formulations exhibiting anti-abuse and anti-dose dumping properties
|
|
DE102006057364B4
(de)
|
2006-12-04 |
2011-08-25 |
Danfoss A/S |
Wasserhydraulische Maschine
|
|
US8470361B2
(en)
|
2006-12-04 |
2013-06-25 |
Orexo Ab |
Non-abusable pharmaceutical composition comprising opioids
|
|
EP2104493A2
(en)
|
2007-01-16 |
2009-09-30 |
Egalet A/S |
Use of i) a polyglycol and n) an active drug substance for the preparation of a pharmaceutical composition for i) mitigating the risk of alcohol induced dose dumping and/or ii) reducing the risk of drug abuse
|
|
DE102007011485A1
(de)
|
2007-03-07 |
2008-09-11 |
Grünenthal GmbH |
Darreichungsform mit erschwertem Missbrauch
|
|
US8329720B1
(en)
|
2007-05-22 |
2012-12-11 |
Pisgah Laboratories, Inc. |
Opioid salts and formulations exhibiting abuse deterrent and anti-dose dumping properties
|
|
US8821928B2
(en)
|
2007-06-04 |
2014-09-02 |
Egalet Ltd. |
Controlled release pharmaceutical compositions for prolonged effect
|
|
HUE032012T2
(en)
|
2007-09-13 |
2017-08-28 |
Cima Labs Inc |
Anti-Abuse Drug Products
|
|
WO2009076236A2
(en)
|
2007-12-06 |
2009-06-18 |
Pain Therapeutics, Inc. |
Micronized opioid compositions, formulations and dosage forms and methods of making same
|
|
EP2067471B1
(en)
|
2007-12-06 |
2018-02-14 |
Durect Corporation |
Oral pharmaceutical dosage forms
|
|
EP2219612A4
(en)
|
2007-12-17 |
2013-10-30 |
Paladin Labs Inc |
FORMULATION WITH TAXED RELEASE AND ABUSE PROTECTION
|
|
TWI454288B
(zh)
|
2008-01-25 |
2014-10-01 |
Gruenenthal Chemie |
藥物劑型
|
|
KR101094231B1
(ko)
|
2008-02-18 |
2011-12-14 |
하나제약 주식회사 |
서방성 고형 제제 및 그의 제조방법
|
|
US8372432B2
(en)
|
2008-03-11 |
2013-02-12 |
Depomed, Inc. |
Gastric retentive extended-release dosage forms comprising combinations of a non-opioid analgesic and an opioid analgesic
|
|
WO2009114648A1
(en)
|
2008-03-11 |
2009-09-17 |
Depomed Inc. |
Gastric retentive extended-release dosage forms comprising combinations of a non-opioid analgesic and an opioid analgesic
|
|
US20110142905A1
(en)
|
2008-08-14 |
2011-06-16 |
Bioneer A/S |
Coated tablets with remaining degradation surface over the time
|
|
DE102008044869A1
(de)
|
2008-08-29 |
2010-03-04 |
Danfoss A/S |
Umkehrosmosevorrichtung
|
|
CN102159193B
(zh)
|
2008-09-18 |
2015-09-16 |
普渡制药公司 |
包含聚(ε-己内酯)的药物剂型
|
|
EP2379111B1
(en)
|
2008-12-12 |
2013-03-20 |
Paladin Labs Inc. |
Narcotic drug formulations with decreased abuse potential
|
|
US8486449B2
(en)
|
2008-12-16 |
2013-07-16 |
Paladin Labs Inc. |
Misuse preventative, controlled release formulation
|
|
NZ594071A
(en)
|
2009-01-26 |
2013-01-25 |
Egalet Ltd |
Controlled release formulations comprising morphine sulphate for continuous treatment of pain
|
|
NZ594207A
(en)
|
2009-02-06 |
2013-03-28 |
Egalet Ltd |
Immediate release composition resistant to abuse by intake of alcohol
|
|
ES2607209T3
(es)
|
2009-02-06 |
2017-03-29 |
Egalet Ltd. |
Composiciones farmacéuticas resistentes al abuso
|
|
GB0909680D0
(en)
|
2009-06-05 |
2009-07-22 |
Euro Celtique Sa |
Dosage form
|
|
AU2010265213B2
(en)
|
2009-06-24 |
2012-08-23 |
Egalet Ltd. |
Controlled release formulations
|
|
WO2010151741A1
(en)
|
2009-06-25 |
2010-12-29 |
Elite Laboratories, Inc. |
Abuse resistant oral dosage forms
|
|
BR112012001466A2
(pt)
|
2009-07-22 |
2020-08-11 |
Grünenthal GmbH |
forma de dosagem resistente à falsificação para opioides sensíveis à oxidação, seu processo de fabricação, e embalagem
|
|
ES2534908T3
(es)
|
2009-07-22 |
2015-04-30 |
Grünenthal GmbH |
Forma de dosificación de liberación controlada extruida por fusión en caliente
|
|
EP3064064A1
(en)
|
2009-09-30 |
2016-09-07 |
Acura Pharmaceuticals, Inc. |
Methods and compositions for deterring abuse
|
|
WO2011079074A1
(en)
|
2009-12-24 |
2011-06-30 |
Acura Phamaceuticals, Inc. |
Pharmaceutical compositions for deterring misuse, abuse, and diversion
|
|
US20120321674A1
(en)
|
2011-02-17 |
2012-12-20 |
Michael Vachon |
Technology for Preventing Abuse of Solid Dosage Forms
|
|
US20130022646A1
(en)
|
2010-02-09 |
2013-01-24 |
Rudnic Edward M |
Controlled Release Formulations of Opioids
|
|
US20110195989A1
(en)
|
2010-02-09 |
2011-08-11 |
Rudnic Edward M |
Controlled Release Formulations of Opioids
|
|
ES2628886T3
(es)
|
2010-02-24 |
2017-08-04 |
Cima Labs Inc. |
Formulaciones resistentes al abuso
|
|
CA2808219C
(en)
|
2010-09-02 |
2019-05-14 |
Gruenenthal Gmbh |
Tamper resistant dosage form comprising inorganic salt
|
|
ES2534847T3
(es)
|
2010-09-02 |
2015-04-29 |
Grünenthal GmbH |
Forma de dosificación inviolable que comprende un polímero aniónico
|
|
WO2012028318A1
(en)
|
2010-09-02 |
2012-03-08 |
Grünenthal GmbH |
Tamper resistant dosage form comprising an anionic polymer
|
|
WO2012040651A2
(en)
|
2010-09-24 |
2012-03-29 |
QRxPharma Ltd. |
Controlled release formulations of opioids
|
|
WO2012061779A1
(en)
|
2010-11-04 |
2012-05-10 |
Abbott Gmbh & Co. Kg |
Drug formulations
|
|
GB201020895D0
(en)
|
2010-12-09 |
2011-01-26 |
Euro Celtique Sa |
Dosage form
|
|
EP2651399A2
(en)
|
2010-12-13 |
2013-10-23 |
Purdue Pharma LP |
Controlled release dosage forms
|
|
PL2826467T3
(pl)
|
2010-12-22 |
2018-01-31 |
Purdue Pharma Lp |
Zamknięte, zabezpieczone przed manipulowaniem formy dozowania o kontrolowanym uwalnianiu
|
|
PH12013501345A1
(en)
|
2010-12-23 |
2022-10-24 |
Purdue Pharma Lp |
Tamper resistant solid oral dosage forms
|
|
JP2014505736A
(ja)
|
2011-02-17 |
2014-03-06 |
キューアールエックスファーマ リミテッド |
固体投薬形態の乱用を防止するための技術
|
|
CN103547259A
(zh)
|
2011-03-25 |
2014-01-29 |
普渡制药公司 |
控制释放药物剂型
|
|
BR112014002022A2
(pt)
|
2011-07-29 |
2017-02-21 |
Gruenenthal Gmbh |
comprimido resistente à violação proporcionando liberação de fármaco imediata
|
|
JP6063462B2
(ja)
|
2011-07-29 |
2017-01-18 |
グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング |
即時薬剤放出を提供するタンパーレジスタント錠剤
|
|
US20140341984A1
(en)
|
2011-09-16 |
2014-11-20 |
Purdue Pharma L.P. |
Tamper resistant pharmaceutical formulations
|
|
AU2012310251B2
(en)
|
2011-09-16 |
2016-01-21 |
Purdue Pharma L.P. |
Tamper resistant immediate release formulations
|
|
CA2850853A1
(en)
|
2011-10-06 |
2013-04-11 |
Grunenthal Gmbh |
Tamper-resistant oral pharmaceutical dosage form comprising opioid agonist and opioid antagonist
|
|
WO2013057570A2
(en)
|
2011-10-18 |
2013-04-25 |
Purdue Pharma L.P. |
Acrylic polymer formulations
|
|
KR20140096062A
(ko)
|
2011-11-17 |
2014-08-04 |
그뤼넨탈 게엠베하 |
약리학적 활성 성분, 오피오이드 길항제 및/또는 혐오제, 폴리알킬렌 옥사이드 및 음이온성 중합체를 포함하는 탬퍼-저항성 경구 약제학적 투여형
|
|
US20150224097A1
(en)
|
2011-11-22 |
2015-08-13 |
Watson Pharmaceuticals, Inc. |
Immediate Release Abuse Deterrent Tablet
|
|
ES2603278T3
(es)
|
2011-12-09 |
2017-02-24 |
Purdue Pharma Lp |
Formas farmacéuticas de dosificación que comprenden poli (epsilon-caprolactona) y óxido de polietileno
|
|
JP2015521988A
(ja)
|
2012-07-06 |
2015-08-03 |
イガレット・リミテッド |
制御放出用乱用防止性医薬組成物
|
|
MX2015016254A
(es)
|
2013-05-29 |
2016-04-20 |
Gruenenthal Gmbh |
Forma de dosificacion resistente al uso indebido con perfil de liberacion bimodal.
|
|
AU2014273227B2
(en)
|
2013-05-29 |
2019-08-15 |
Grunenthal Gmbh |
Tamper-resistant dosage form containing one or more particles
|